Navigating Tariffs and Supply Chain Disruptions: Program Management Strategies for Pharmaceutical Commercial Success

Intense difficulties plague the pharmaceutical industry because of trade conflicts, implemented tariffs, and supply network disruptions that span multiple continents. The pharmaceutical sector encountered weaknesses due to political disputes and large-scale disruptions when the U.S.-China trade war started. The COVID-19 pandemic erupted, leading to cost hikes, medication delivery slowdowns, and an emptiness of essential medical resources emptiness. The situation worsens because API and essential material export duty barriers require immediate strategic solutions. Multiple complex industry challenges require companies to use program management as an essential success tool for achieving management success. Current program management requires developed methodologies to incorporate predictive risk assessment and improved capability to expand supply networks, manage regulatory compliance requirements, and implement flexible project methods for maintaining continuous profitable outcomes. The four strategic approaches companies must adopt are scenario planning integrated with multi-sourcing, predictive analytics, and tariff engineering to develop resilient supply chains in response to potential situations. Strategy implementation through integrated program management frameworks enables pharmaceutical firms to create risk-resistant organizations capable of seizing market possibilities without affecting external market changes. A strategic program management approach is an important weapon that helps businesses defeat supply chain instabilities and tariffs within their operations. According to the demands, pharmaceutical organizations must develop operational resilience factors for ongoing business success in volatile global markets. The research findings provide crucial intelligence to organizations with fragile global supply chain systems regarding becoming adaptable and developing innovative approaches for future planning.

Institutions

Publication Details

Journal
International Journal of Innovative Research in Science Engineering and Technology
Published
2025-05-14
DOI
https://doi.org/10.15680/ijirset.2025.1405010
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Navigating Tariffs and Supply Chain Disruptions: Program Management Strategies for Pharmaceutical Commercial Success

International Journal of Innovative Research in Science Engineering and Technology
Pharmaceutical Economics and Policy
article

Navigating Tariffs and Supply Chain Disruptions: Program Management Strategies for Pharmaceutical Commercial Success

article en

Abstract

Intense difficulties plague the pharmaceutical industry because of trade conflicts, implemented tariffs, and supply network disruptions that span multiple continents. The pharmaceutical sector encountered weaknesses due to political disputes and large-scale disruptions when the U.S.-China trade war started. The COVID-19 pandemic erupted, leading to cost hikes, medication delivery slowdowns, and an emptiness of essential medical resources emptiness. The situation worsens because API and essential material export duty barriers require immediate strategic solutions. Multiple complex industry challenges require companies to use program management as an essential success tool for achieving management success. Current program management requires developed methodologies to incorporate predictive risk assessment and improved capability to expand supply networks, manage regulatory compliance requirements, and implement flexible project methods for maintaining continuous profitable outcomes. The four strategic approaches companies must adopt are scenario planning integrated with multi-sourcing, predictive analytics, and tariff engineering to develop resilient supply chains in response to potential situations. Strategy implementation through integrated program management frameworks enables pharmaceutical firms to create risk-resistant organizations capable of seizing market possibilities without affecting external market changes. A strategic program management approach is an important weapon that helps businesses defeat supply chain instabilities and tariffs within their operations. According to the demands, pharmaceutical organizations must develop operational resilience factors for ongoing business success in volatile global markets. The research findings provide crucial intelligence to organizations with fragile global supply chain systems regarding becoming adaptable and developing innovative approaches for future planning.

International Journal of Innovative Research in Science Engineering and TechnologyVol. 14(05)
Gilead Sciences (United Kingdom) (GB), Gilead Sciences (United States) (US), Gilead Sciences (Australia) (AU)
Openalex Percentile: Top 85%
Pharmaceutical Economics and Policy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.